Evidence map›Paper›PMID 38855287›Full record

ArticleWorld journal of otorhinolaryngology - head and neck surgery2024

Recovery rates of persistent post-COVID-19 olfactory dysfunction using psychophysical assessment: A longitudinal cohort study.

Jeremy P Tervo, Patricia T Jacobson, Brandon J Vilarello, Tiana M Saak, Francesco F Caruana, Liam W Gallagher, Joseph B Gary, David A Gudis, Paule V Joseph, D P Devanand and 2 more

Abstract read
In one paragraph

Article in World journal of otorhinolaryngology - head and neck surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Therapeutic Effects ofLife (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jeremy P TervoColumbia University Vagelos College of Physicians and Surgeons New York New York USA.ORCID 0000-0002-8883-8566
Patricia T JacobsonDepartment of Otolaryngology-Head and Neck Surgery New York-Presbyterian/Columbia University Irving Medical Center New York New York USA.
Brandon J VilarelloColumbia University Vagelos College of Physicians and Surgeons New York New York USA.
Tiana M SaakColumbia University Vagelos College of Physicians and Surgeons New York New York USA.
Francesco F CaruanaDepartment of Otolaryngology-Head and Neck Surgery University of Pittsburgh Pittsburgh Pennsylvania USA.
Liam W GallagherDepartment of Otolaryngology-Head and Neck Surgery University of Minnesota Minneapolis Minnesota USA.
Joseph B GaryColumbia University Vagelos College of Physicians and Surgeons New York New York USA.
David A GudisColumbia University Vagelos College of Physicians and Surgeons New York New York USA.ORCID 0000-0002-1938-9349
Paule V JosephNational Institute of Alcohol Abuse and Alcoholism, Section of Sensory Science and Metabolism & National Institute of Nursing Research Bethesda Maryland USA.
D P DevanandColumbia University Vagelos College of Physicians and Surgeons New York New York USA.
Terry E GoldbergDepartment of Psychiatry New York-Presbyterian/Columbia University Irving Medical Center New York New York USA.
Jonathan B OverdevestColumbia University Vagelos College of Physicians and Surgeons New York New York USA.

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Sensory Science and Metabolism; Molecular and Neuronal Mechanisms ZIAAA000136 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI JOSEPH, PAULE · 2021 to 2025
$3.2M
The Brief Research in Aging and Interdisciplinary NeurosciencesT35AG044303 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Sachin Agarwal, Jennifer Jaie Manly · 2013 to 2026
$1.9M
Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19K23DC019678 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI OVERDEVEST, JONATHAN B · 2021 to 2025
$893k
Chemosensation and COVID-19ZIAAA000138 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI JOSEPH, PAULE · 2022 to 2024
$188k
NCATS NIH HHS UL1 TR001873NIA NIH HHS T35 AG044303NIDCD NIH HHS K23 DC019678
6 · The paper itself

Abstract

Objectives: Persistent olfactory dysfunction (OD) following loss of smell associated with SARS-CoV-2 infection is a major feature of long COVID. Perspectives on the prevalence of persistent OD predominantly rely on self-reported olfactory function. Few studies have tracked longitudinal rates of recovery using psychophysical assessment among patients presenting for evaluation of persistent OD beyond a window of acute recovery. Data anchored in standardized testing methods are needed to counsel patients who fail to acutely regain their sense of smell. This study aims to quantify the degree of persistent OD in post-COVID-19 patients who experience subjective and psychophysical OD. Methods: We grouped participants presenting for OD evaluation into cohorts based on both subjective and psychophysical olfactory status at a baseline assessment and assessed their olfactory abilities with a visual analogue scale and the Sniffin' Sticks extended test at baseline and 1-year time points. Participants had confirmed a history of COVID-19 by lab evaluation or clinical diagnosis if lab evaluation was not available. Results: Baseline olfactory evaluation was completed by 122 participants, 53 of whom completed the 1-year follow-up assessment. Among participants presenting with perceived OD, 74.5% had confirmed psychophysical OD at baseline, with 55.1% at 1-year follow-up. Participants had reliable trends in self-rated versus psychophysically tested olfactory function at both time points. The total threshold, discrimination, and identification (TDI) score improved by +3.25 points in the cohort with psychophysical OD ( Conclusions: OD persists in a significant number of patients who fail to acutely recovery their sense of smell after COVID-19, with many demonstrating lingering deficits at 1-year. Improvements in threshold, but not discrimination or identification, most significantly mediate improvement of total TDI score at follow-up.

Indexed as

long COVIDolfactionpost‐COVID conditionsmell dysfunction

Identifiers

PMID38855287
PMCPMC11156685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.